Swine flu vaccine gives boost to GSK

Soaring global demand for swine flu vaccinations is expected to give drug giant GlaxoSmithKline a £1bn (€1.1bn) sales boost in the final three months of the year, the group confirmed today.

Glaxo said it had shipped 25 million doses of its swine flu vaccine so far and was “in good shape” to meet orders for 440 million worldwide.